Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $77,512 | 11 | 57.4% |
| Honoraria | $44,340 | 10 | 32.8% |
| Travel and Lodging | $9,816 | 25 | 7.3% |
| Food and Beverage | $3,335 | 45 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $126,515 | 73 | $0 (2023) |
| Amgen Inc. | $6,000 | 3 | $0 (2024) |
| Allergan, Inc. | $710.84 | 9 | $0 (2022) |
| Janssen Global Services, LLC | $695.00 | 1 | $0 (2024) |
| Horizon Pharma plc | $680.48 | 1 | $0 (2017) |
| MERZ NORTH AMERICA, INC. | $211.22 | 2 | $0 (2017) |
| AbbVie Inc. | $180.18 | 1 | $0 (2023) |
| Galderma Laboratories, L.P. | $10.65 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,695 | 4 | Amgen Inc. ($6,000) |
| 2023 | $4,459 | 6 | Horizon Therapeutics plc ($4,279) |
| 2022 | $14,895 | 16 | Horizon Therapeutics plc ($14,675) |
| 2021 | $3,196 | 3 | Horizon Therapeutics plc ($3,000) |
| 2020 | $44,101 | 24 | Horizon Therapeutics plc ($44,101) |
| 2019 | $60,497 | 30 | Horizon Therapeutics plc ($60,460) |
| 2018 | $194.66 | 2 | Allergan Inc. ($194.66) |
| 2017 | $966.10 | 6 | Horizon Pharma plc ($680.48) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/19/2024 | Amgen Inc. | TEPEZZA (Biological) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/10/2024 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $695.00 | General |
| 01/13/2024 | Amgen Inc. | TEPEZZA (Biological) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/04/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $1,500.00 | General |
| Category: TEPEZZA | ||||||
| 11/04/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | Cash or cash equivalent | $29.49 | General |
| Category: TEPEZZA | ||||||
| 11/03/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: TEPEZZA | ||||||
| 01/15/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $180.18 | General |
| 01/14/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $2,500.00 | General |
| Category: TEPEZZA | ||||||
| 01/14/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $99.20 | General |
| Category: TEPEZZA | ||||||
| 11/04/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $122.33 | General |
| Category: TEPEZZA | ||||||
| 06/10/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $6,000.00 | General |
| Category: TEPEZZA | ||||||
| 06/10/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $3,000.00 | General |
| Category: TEPEZZA | ||||||
| 06/10/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Travel and Lodging | Cash or cash equivalent | $1,186.77 | General |
| Category: TEPEZZA | ||||||
| 06/10/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Travel and Lodging | Cash or cash equivalent | $1,012.20 | General |
| Category: TEPEZZA | ||||||
| 06/10/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Travel and Lodging | Cash or cash equivalent | $489.30 | General |
| Category: TEPEZZA | ||||||
| 06/10/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Travel and Lodging | Cash or cash equivalent | $457.00 | General |
| Category: TEPEZZA | ||||||
| 06/10/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $104.23 | General |
| Category: TEPEZZA | ||||||
| 06/10/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $64.66 | General |
| Category: TEPEZZA | ||||||
| 06/10/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $49.68 | General |
| Category: TEPEZZA | ||||||
| 06/10/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: TEPEZZA | ||||||
| 05/14/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: TEPEZZA | ||||||
| 01/17/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $71.77 | General |
| Category: FACIAL AESTHETICS | ||||||
| 01/16/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| Category: TEPEZZA | ||||||
| 01/16/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $139.85 | General |
| Category: TEPEZZA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 83 | 85 | $7,492 | $2,021 |
| 2022 | 6 | 116 | 117 | $41,052 | $10,638 |
| 2021 | 6 | 136 | 144 | $20,814 | $5,454 |
| 2020 | 3 | 64 | 67 | $5,450 | $1,561 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 20 | 21 | $5,988 | $1,582 | 26.4% |
| 92081 | Exam of visual field with limited testing | Facility | 2023 | 30 | 31 | $1,240 | $369.04 | 29.8% |
| 92285 | Photography of content of eyes | Facility | 2023 | 33 | 33 | $264.00 | $70.47 | 26.7% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2022 | 12 | 12 | $30,464 | $7,834 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 13 | 13 | $3,411 | $970.63 | 28.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 16 | 16 | $3,468 | $882.84 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 12 | 13 | $2,309 | $546.38 | 23.7% |
| 92081 | Exam of visual field with limited testing | Facility | 2022 | 28 | 28 | $1,120 | $327.28 | 29.2% |
| 92285 | Photography of content of eyes | Facility | 2022 | 35 | 35 | $280.00 | $76.31 | 27.3% |
| 68810 | Insertion of probe into the tear duct | Facility | 2021 | 11 | 12 | $6,987 | $1,620 | 23.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 18 | 22 | $4,941 | $1,413 | 28.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 23 | 23 | $4,634 | $1,117 | 24.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 15 | 18 | $2,804 | $944.18 | 33.7% |
| 92081 | Measurement of field of vision during daylight conditions, limited examination | Facility | 2021 | 28 | 28 | $1,120 | $279.51 | 25.0% |
| 92285 | Photography of content of eyes | Facility | 2021 | 41 | 41 | $328.00 | $79.68 | 24.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 19 | 22 | $4,482 | $1,309 | 29.2% |
| 92081 | Measurement of field of vision during daylight conditions | Facility | 2020 | 19 | 19 | $760.00 | $196.43 | 25.8% |
| 92285 | Photography of content of eyes | Facility | 2020 | 26 | 26 | $208.00 | $55.57 | 26.7% |
About Dr. Roger Dailey, MD
Dr. Roger Dailey, MD is a Ophthalmology healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558312835.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roger Dailey, MD has received a total of $135,004 in payments from pharmaceutical and medical device companies, with $6,695 received in 2024. These payments were reported across 91 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($77,512).
As a Medicare-enrolled provider, Dailey has provided services to 399 Medicare beneficiaries, totaling 413 services with total Medicare billing of $19,673. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmic Plastic and Reconstructive Surgery
- Location Portland, OR
- Active Since 05/12/2006
- Last Updated 08/15/2018
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1558312835
Products in Payments
- TEPEZZA (Drug) $46,283
- KRYSTEXXA (Biological) $17,250
- TEPEZZA (Biological) $6,000
- TEPRO (Drug) $680.48
- BOTOX (Biological) $230.34
- VUITY (Drug) $147.70
- Xeomin (Biological) $90.20
- RESTASIS (Drug) $64.74
- RESTASIS MULTIDOSE (Drug) $51.17
- BOTOX COSMETIC (Biological) $36.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Portland
James Rosenbaum, M.d, M.D
Ophthalmology — Payments: $293,531
Dr. Mark Pennesi, Md Phd, MD PHD
Ophthalmology — Payments: $185,243
Peter Francis, Md, MD
Ophthalmology — Payments: $156,902
Dr. Brian Chan-Kai, M.d, M.D
Ophthalmology — Payments: $123,899
Dr. Mark Terry, Md, MD
Ophthalmology — Payments: $112,572
Eric Suhler, Md, MD
Ophthalmology — Payments: $103,504